Topcon Acquires IRIS to Advance AI-Powered Retinal Screenings and Connected Eye Care

Topcon收购IRIS以推进人工智能驱动的视网膜筛查和互联眼科护理

July 31, 2025

2025年7月31日

Topcon Healthcare, Inc. has acquired Intelligent Retinal Imaging Systems (IRIS), a US-based provider of cloud-based AI-assisted retinal screening technology. The acquisition supports Topcon’s strategic vision to enhance its Healthcare from the Eye™ initiative, strengthening clinical decision-making and improving early detection and care coordination for ocular and systemic diseases, particularly in patients with diabetic retinopathy and other diabetic eye diseases..

Topcon Healthcare公司收购了美国基于云的AI辅助视网膜筛查技术提供商Intelligent Retinal Imaging Systems（IRIS）。此次收购支持了Topcon的战略愿景，即加强其“从眼睛到医疗”计划，强化临床决策，并改善眼部及全身疾病的早期检测和护理协调，特别是针对糖尿病视网膜病变及其他糖尿病眼病患者。

Supporting a Connected Care Model

支持互联护理模式

Topcon’s Healthcare from the Eye program is designed to improve communication and coordination between primary care providers (PCPs) and eye care professionals (ECPs). With the addition of IRIS, Topcon aims to better identify at-risk patients during PCP visits and enable more efficient referrals to optometrists or ophthalmologists for specialized evaluations.

Topcon的“从眼部开始的医疗保健”计划旨在改善初级保健医生（PCPs）与眼科护理专业人员（ECPs）之间的沟通与协调。通过引入IRIS，Topcon旨在更好地在初级保健访问期间识别高风险患者，并实现更高效的转诊给验光师或眼科医生以进行专门评估。

By leveraging AI-analyzed retinal data, eye care professionals can detect signs of ocular, systemic, or even neurological disease and refer patients back to primary care for further management when needed..

通过利用人工智能分析的视网膜数据，眼科护理专业人员可以检测出眼部、系统性甚至神经性疾病的迹象，并在需要时将患者转诊回初级保健机构进行进一步管理。

Enhancing the Harmony Platform

增强和谐平台

The integration of IRIS also strengthens Topcon’s Harmony connected care platform, a cloud-based system that unifies imaging, clinical insights, and AI analytics across multiple care settings. Following the acquisition, Harmony users will gain access to IRIS’s referral and communication tools, enhancing their ability to coordinate care and promote shared clinical decision-making.

IRIS的整合还加强了Topcon的Harmony互联护理平台，这是一个基于云的系统，可在多种护理环境中统一成像、临床洞察和AI分析。收购完成后，Harmony用户将能够使用IRIS的转诊和沟通工具，增强他们协调护理和促进共同临床决策的能力。

The combination is expected to improve patient compliance and support infrastructure for integrated workflows..

该组合有望提高患者的依从性，并为集成工作流程提供支持基础设施。

Overview of IRIS Retinal Screening Capabilities

IRIS视网膜筛查功能概述

Founded in 2012, IRIS offers a camera-agnostic, cloud-based platform designed for AI-assisted screening of diabetic retinopathy. The platform has facilitated more than 1.8 million screenings, identifying over 279,000 cases of diabetic retinopathy across more than 650 healthcare organizations. IRIS is widely adopted in routine clinical settings, Federally Qualified Health Centers (FQHCs), and large health systems.

IRIS 成立于2012年，提供了一个与相机无关的、基于云的平台，旨在通过人工智能辅助筛查糖尿病视网膜病变。该平台已经促成了超过180万次筛查，在650多家医疗机构中识别出超过27.9万例糖尿病视网膜病变病例。IRIS 已被广泛应用于常规临床环境、联邦合格健康中心 (FQHC) 以及大型医疗系统中。

Its broad camera compatibility and seamless electronic medical record (EMR) integration make it highly scalable across various clinical environments..

其广泛的相机兼容性和无缝的电子病历（EMR）集成使其在各种临床环境中具有高度的可扩展性。

Leadership Perspectives on the Acquisition

领导者对收购的看法

Jacques Gilbert, Chief Strategy and Business Development Officer at Topcon Healthcare, emphasized the strategic alignment:

佳能医疗首席战略与业务发展官雅克·吉尔伯特强调了战略一致性：

'This acquisition reflects our long-term strategy to connect the continuum of care through intelligent platforms that bring together data, workflow, and real-time decision support. IRIS enables us to expand the reach of the Healthcare from the Eye™ initiative into primary care, strengthening coordination between PCPs and ECPs, and ensuring patients receive timely, targeted care.'.

“此次收购反映了我们通过智能平台连接连续护理的战略，这些平台将数据、工作流程和实时决策支持结合在一起。IRIS使我们能够扩大‘从眼睛到医疗™’计划在初级保健领域的覆盖范围，加强初级保健医生（PCP）和眼科护理专业人员（ECP）之间的协调，确保患者获得及时、有针对性的护理。”

Steven Martin, CEO of IRIS, also expressed enthusiasm about the partnership:

IRIS首席执行官史蒂文·马丁也对此次合作表示了热情：

'With Topcon Healthcare’s investment in connected care infrastructure, we’re well-positioned to expand our impact. Together, we’ll ensure providers of all sizes can confidently deliver preventive screenings that improve outcomes and reduce disparities.'

“通过拓普康医疗对互联护理基础设施的投资，我们已经做好了扩大影响力的准备。我们将共同努力，确保各种规模的医疗服务提供者都能自信地提供改善结果并减少差异的预防性筛查。”